CD40LG, CD40 ligand, 959

N. diseases: 453; N. variants: 25
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0008354
Disease: Cholera
Cholera
0.010 AlteredExpression disease BEFREE The increased Tfh cells expressing CD40L recognize cholera toxin most prominently, with lessened responses to V. cholerae membrane preparation (MP) and V. cholerae cytolysin (VCC). 30580014 2020
CUI: C0009319
Disease: Colitis
Colitis
0.010 AlteredExpression disease BEFREE Development of colitis required CD40L expression in CD4+ T cells, and the disease was partially ameliorated by IFNγ neutralization. 31559420 2020
CUI: C0751356
Disease: Idiopathic Inflammatory Myopathies
Idiopathic Inflammatory Myopathies
0.010 Biomarker disease BEFREE In BAL fluid, CD4+ T cells from 3 of 4 patients with IIM/antisynthetase syndrome responded to stimulation with HisRS protein, as measured by the median fold change in CD40L expresssion in stimulated cells compared to unstimulated cells (median fold change 3.6, interquartile range [IQR] 2.7-14.7), and 2 of 3 patients with IIM/antisynthetase syndrome had the highest responses to HisRS<sub>11-23</sub> (median fold change 88, IQR 27-149)<sub>.</sub> In PBMCs, CD4+ T cells from 14 of 18 patients with IIM/antisynthetase syndrome responded to HisRS protein (median fold change 7.38, IQR 2.69-31.86; P < 0.001), whereas a HisRS<sub>11-23</sub> response was present in 11 of 14 patients with IIM/antisynthetase syndrome (median fold change 3.4, IQR 1.87-10.9; P < 0.001). 31403245 2020
CUI: C1262313
Disease: Invasive Fungal Infections
Invasive Fungal Infections
0.010 Biomarker group BEFREE CD154+ mould-reactive T cells were proposed as a novel biomarker in the diagnosis of invasive mycoses. 31095327 2020
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 31827233 2020
CUI: C2609059
Disease: Antisynthetase syndrome
Antisynthetase syndrome
0.010 Biomarker disease BEFREE In BAL fluid, CD4+ T cells from 3 of 4 patients with IIM/antisynthetase syndrome responded to stimulation with HisRS protein, as measured by the median fold change in CD40L expresssion in stimulated cells compared to unstimulated cells (median fold change 3.6, interquartile range [IQR] 2.7-14.7), and 2 of 3 patients with IIM/antisynthetase syndrome had the highest responses to HisRS<sub>11-23</sub> (median fold change 88, IQR 27-149)<sub>.</sub> In PBMCs, CD4+ T cells from 14 of 18 patients with IIM/antisynthetase syndrome responded to HisRS protein (median fold change 7.38, IQR 2.69-31.86; P < 0.001), whereas a HisRS<sub>11-23</sub> response was present in 11 of 14 patients with IIM/antisynthetase syndrome (median fold change 3.4, IQR 1.87-10.9; P < 0.001). 31403245 2020
CUI: C0001883
Disease: Airway Obstruction
Airway Obstruction
0.010 Biomarker group BEFREE However, the loss of the epithelium and airway obstruction were significantly improved in mice treated with TJ-M2010-5 combined with MR-1. 30472390 2019
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.010 Biomarker phenotype BEFREE In the absence of fetal heart failure, concentrations of all maternal serum cytokines and hormones were similar in cases of fetal congenital heart defects and controls, while maternal serum soluble CD40 ligand concentrations were increased only in fetal arrhythmias. 30273582 2019
CUI: C0005866
Disease: Bluetongue infection
Bluetongue infection
0.010 Biomarker disease BEFREE Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera. 30394662 2019
CUI: C0006272
Disease: Bronchiolitis Obliterans
Bronchiolitis Obliterans
0.010 Biomarker disease BEFREE In heterotopic tracheal transplantation models, TJ-M2010-5 combined with MR-1 could ameliorate the development of OB. 30472390 2019
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.010 Biomarker disease BEFREE The present study evaluated the role of CD40/CD40L in LGG and GBM in differentiating isocitrate dehydrogenase (IDH) wild-type and IDH-mutant GBM. 31125770 2019
CUI: C0018081
Disease: Gonorrhea
Gonorrhea
0.010 Biomarker disease BEFREE C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections. 31661468 2019
CUI: C0019655
Disease: Histoplasmosis
Histoplasmosis
0.010 Biomarker disease BEFREE Genetic defects in the interferon-gamma (IFN-γ)/STAT1 signaling pathway, CD40/CD40 ligand- and IL12/IL12-receptor-mediated crosstalk between phagocytes and T-cells, and STAT3-mediated Th17 differentiation have been reported in HIV-negative children with talaromycosis and other endemic mycoses such as histoplasmosis, coccidioidomycosis, and paracoccidioidomycosis. 31572394 2019
CUI: C0023364
Disease: Leptospirosis
Leptospirosis
0.010 Biomarker disease BEFREE This study was undertaken as an attempt to compare a battery of tools such as immunochromatographic test (ICT), microscopic agglutination test (MAT), immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) and in-house polymerase chain reaction (PCR) to detect leptospirosis. 30429392 2019
CUI: C0024115
Disease: Lung diseases
Lung diseases
0.010 Biomarker group BEFREE This study supports the idea that several organs are exposed during ALI development, and particularly when such experimental ALI aims at mimicking transfusion-associated ALI; nevertheless, preventive treatment inhibiting CD40/CD40L (sCD40L) complex formation provides protection from lung disease as well as disease of other organs. 30784079 2019
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.010 Biomarker phenotype BEFREE Moreover, IGM-18 exerted an analgesic effect on formalin-induced orofacial pain and chronic constriction injury-induced neuropathic pain, demonstrating the involvement of TRPM8 channels in these two pain models. 31703254 2019
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE To understand the role of TRPM8 in pain perception, we tested two specific TRPM8-modulating compounds, an antagonist (IGM-18) and an agonist (IGM-5), in either acute or chronic animal pain models using male Sprague-Dawley rats or CD1 mice, after systemic or topical routes of administration. 31703254 2019
CUI: C0037023
Disease: Sialadenitis
Sialadenitis
0.010 Biomarker disease BEFREE Additionally, we dosed MR1 (anti-CD154 antibody) in NOD mice after the onset of SS-like disease and examined the effects of MR1 treatment on sialadenitis, autoantibody production, SG leucocyte infiltration, gene expression downstream of CD40 and acquaporin 5 (AQP5) expression. 30902822 2019
CUI: C0040021
Disease: Thromboangiitis Obliterans
Thromboangiitis Obliterans
0.010 Biomarker disease BEFREE Peripheral blood mononuclear cells (PBMCs) were isolated from healthy controls (N=54), patients with Grave's disease (N=26), and TAO patients (N=125), and stimulated with CpG/CD40L. 30888403 2019
CUI: C0149678
Disease: Epstein-Barr Virus Infections
Epstein-Barr Virus Infections
0.010 Biomarker group BEFREE Since methylation can affect gene expression, and so cell differentiation and immune evasion, we hypothesised that EBV-driven hypomethylation may affect the interaction between EBV infection and MS. We interrogated an existing dataset comprising three individuals with whole-genome bisulfite sequencing data from EBV transformed B cells and CD40L-activated B cells. 31619767 2019
CUI: C0206062
Disease: Lung Diseases, Interstitial
Lung Diseases, Interstitial
0.010 AlteredExpression group BEFREE MLN enlargement predicts TFS and hospitalization risk in ILD and is associated with decreased levels of a key circulating cytokine, soluble CD40L. 30216085 2019
CUI: C0748168
Disease: Pulmonary Pathology
Pulmonary Pathology
0.010 Biomarker disease BEFREE Incorporation of CD40L into rAd5-based MERS-CoV S1 vaccine targeting molecule and molecular adjuvants not only enhances immunogenicity and efficacy but also prevents inadvertent pulmonary pathology after viral challenge, thereby offering a promising strategy to enhance safety and potency of vaccines. 30911758 2019
CUI: C1378703
Disease: Renal carcinoma
Renal carcinoma
0.010 Biomarker disease BEFREE Immune Check Point CD40-CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells. 31519562 2019
CUI: C1384666
Disease: hearing impairment
hearing impairment
0.010 Biomarker phenotype BEFREE Hearing impairment was more prevalent in patients with IGM compared to healthy controls, as assessed by PTA and DPOAEs. 31338751 2019
CUI: C1527336
Disease: Sjogren's Syndrome
Sjogren's Syndrome
0.010 Biomarker disease BEFREE CD40-CD154 interactions play an important role in key pathological processes in a mouse model of SS, suggesting that blockade of this costimulatory pathway in the clinic may have beneficial therapeutic effects in patients suffering from this autoimmune exocrinopathy. 30902822 2019